Alnylam Pharmaceuticals: Needham cuts target price to $243 from $357
ALNY•Needham cut its target price for Alnylam Pharmaceuticals to $243 from $357.
Related News
Caterpillar Inc target price cut to $785 from $1,045 by Jefferies
CAT•
Digital Realty Trust target price raised to $240 from $235 by HSBC
DLR•
Jefferies cuts Carrier Global target price to $70 from $90
CARR•
JP Morgan raises Kymera Therapeutics target price to $141 from $140
KYMR•
Tech rout hits South Korea, Taiwan; Jakarta faces worst month in 18 years
SPY•